Table 2 Analysis of Variance for serum hormone levels and sperm characteristics. Differences for sperm characteristics resulted statistically significant among patients treated with different treatment modalities as well as testicular volume variations whilst serum hormone levels remained comparable in all the groups
Analysis of variance (ANOVA one-way) | |||||
|---|---|---|---|---|---|
Factor | Group | N | Mean | Standard deviation | p-value |
Sperm concentration (mill/ml) | Surgery | 29 | 19,72 | 14,15 | < 0,0001 |
Hormonal therapy | 93 | 31,94 | 21,27 | ||
Combined | 51 | 23,45 | 15,97 | ||
No treatment | 19 | 7,53 | 3,85 | ||
Totale | 192 | 25,42 | 19,34 | ||
Progressive sperm motility (%) | Surgery | 29 | 33,34 | 5,89 | < 0,0001 |
Hormonal therapy | 93 | 50,28 | 13,07 | ||
Combined | 51 | 38,92 | 5,83 | ||
No treatment | 19 | 9,95 | 6,43 | ||
Totale | 192 | 40,71 | 15,75 | ||
Normal sperm morphology (%) | Surgery | 29 | 3,83 | 1,73 | < 0,0001 |
Hormonal therapy | 93 | 13,44 | 6,92 | ||
Combined | 51 | 14,53 | 6,60 | ||
No treatment | 19 | 1,74 | 1,45 | ||
Totale | 192 | 11,12 | 7,59 | ||
Inhibin B (pg/ml) | Surgery | 29 | 189,45 | 70,02 | 0,063 |
Hormonal therapy | 93 | 211,76 | 46,02 | ||
Combined | 51 | 211,55 | 67,40 | ||
No treatment | 19 | 236,84 | 76,27 | ||
Totale | 192 | 210,82 | 60,11 | ||
FSH (IU/L) | Surgery | 29 | 3,31 | 1,33 | 0,105 |
Hormonal therapy | 93 | 3,10 | 1,78 | ||
Combined | 51 | 2,59 | 0,68 | ||
No treatment | 19 | 3,26 | 1,45 | ||
Totale | 192 | 3,01 | 1,48 | ||
Testosterone (nmol/L) | Surgery | 29 | 22,69 | 7,10 | 0,672 |
Hormonal therapy | 93 | 23,12 | 6,21 | ||
Combined | 51 | 22,73 | 5,62 | ||
No treatment | 19 | 21,21 | 5,15 | ||
Totale | 192 | 22,76 | 6,08 | ||
Total testis volume, US (ml) | Surgery | 29 | 26,83 | 5,66 | 0,034 |
Hormonal therapy | 93 | 26,61 | 5,45 | ||
Combined | 51 | 27,63 | 7,10 | ||
No treatment | 19 | 22,95 | 4,75 | ||
Totale | 192 | 26,55 | 6,00 | ||